Alpine Global Management’s Acceleron Pharma XLRN Stock Holding History

Alpine Global Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,846	Closed	-$1.69M	–	876
2021 Q3	$1.69M	Buy	+9,846	New	+$1.29M	0.38%	55

Alpine Global Management's XLRN Position: Q4 2021 in Review

Alpine Global Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 9,846 shares — an estimated $1.69M sold.

Alpine Global Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $1.69M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Alpine Global Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Alpine Global Management sold 9,846 Acceleron Pharma shares in Q4 2021, an estimated $1.69M.
Alpine Global Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Alpine Global Management's Acceleron Pharma position peaked at $1.69M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Alpine Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.